GlaxoSmithKline Pharmaceuticals Share Price
₹2,274.45 +31.25 (1.39%)
28 Dec, 2024 01:27
Start SIP in GLAXO
Start SIPPerformance
- Low
- ₹2,241
- High
- ₹2,284
- 52 Week Low
- ₹1,797
- 52 Week High
- ₹3,088
- Open Price₹2,243
- Previous Close₹2,243
- Volume40,292
Investment Returns
- Over 1 Month -4.98%
- Over 3 Month -16.6%
- Over 6 Month -12.56%
- Over 1 Year + 28.73%
Smart Investing Starts Here Start SIP with GlaxoSmithKline Pharmaceuticals for Steady Growth!
GlaxoSmithKline Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 57.1
- PEG Ratio
- 13.6
- Market Cap Cr
- 38,531
- P/B Ratio
- 21.7
- Average True Range
- 62.37
- EPS
- 47.33
- Dividend Yield
- 1.9
- MACD Signal
- -60.54
- RSI
- 39.61
- MFI
- 41.45
GlaxoSmithKline Pharmaceuticals Financials
GlaxoSmithKline Pharmaceuticals Technicals
EMA & SMA
Current Price
₹2,274.45
+
31.25
(1.39%)
- Bullish Moving Average 2
- Bearish Moving Average 14
- 20 Day
- ₹2,324.90
- 50 Day
- ₹2,436.99
- 100 Day
- ₹2,504.23
- 200 Day
- ₹2,422.16
Resistance and Support
2266.55
- R3 2,335.30
- R2 2,309.75
- R1 2,292.10
- S1 2,248.90
- S2 2,223.35
- S3 2,205.70
GlaxoSmithKline Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
GlaxoSmithKline Pharmaceuticals F&O
About GlaxoSmithKline Pharmaceuticals
- NSE Symbol
- GLAXO
- BSE Symbol
- 500660
- Managing Director
- Mr. B Akshikar
- ISIN
- INE159A01016
Similar Stocks to GlaxoSmithKline Pharmaceuticals
GlaxoSmithKline Pharmaceuticals FAQs
GlaxoSmithKline Pharmaceuticals share price is ₹2,274 As on 28 December, 2024 | 01:13
The Market Cap of GlaxoSmithKline Pharmaceuticals is ₹38530.5 Cr As on 28 December, 2024 | 01:13
The P/E ratio of GlaxoSmithKline Pharmaceuticals is 57.1 As on 28 December, 2024 | 01:13
The PB ratio of GlaxoSmithKline Pharmaceuticals is 21.7 As on 28 December, 2024 | 01:13
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.